• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Sybase

Sybase

  1. Syros to Present Biomarker Data from Ongoing Phase 2 Clinical Trial of SY -1425 at ESH Conference on AML

    Syros to Present Biomarker Data from Ongoing Phase 2 Clinical Trial of SY -1425 at ESH Conference on AML

1234

©2017 Morningstar Advisor. All right reserved.